Anti-cytomegalovirus preemptive therapy to prevent cytomegalovirus disease in HIV-infected patients: a systematic review.

Prenali Dwisthi Sattwika Yanri Wijayanti SubrontoHeni RetnowulanKarina Ambar SattwikaDetty Siti Nurdiati

Published in: Infectious diseases (London, England) (2023)

With the advent of HAART, a limited number of studies have been performed to explore anti-CMV preemptive therapy due to the improved outcomes of HIV patients with CMV viremia. Therefore, optimal HAART should take precedence over anti-CMV preemptive therapy. The protocol for this review was registered in the Prospective Register of Systematic Reviews (CRD42020145765).

Keyphrases

hiv infected patients
antiretroviral therapy
hiv infected
systematic review
human immunodeficiency virus
randomized controlled trial
hiv positive
hepatitis c virus
stem cells
adipose tissue
cell therapy
skeletal muscle
meta analyses
case control